表紙
市場調查報告書

心臟監測、心律管理設備的全球市場 - 至2024年的預測:心電圖 (ECG),植入式迴路記錄器 (ILR),心臟事件記錄器,行動心電遙測 (MCT),心臟去顫器,心律調節器

Cardiac Monitoring & Cardiac Rhythm Management Devices Market CM (ECG, ILR, Event Monitors, MCT), CRM (Defibrillator (ICD (CRT D), External Defibrillators (AED)), Pacemaker (CRT P, Dual Chamber Pacemaker)), End User (Hospitals) - Global Forecast to 2024

出版商 MarketsandMarkets 商品編碼 263650
出版日期 內容資訊 英文 187 Pages
訂單完成後即時交付
價格
Back to Top
心臟監測、心律管理設備的全球市場 - 至2024年的預測:心電圖 (ECG),植入式迴路記錄器 (ILR),心臟事件記錄器,行動心電遙測 (MCT),心臟去顫器,心律調節器 Cardiac Monitoring & Cardiac Rhythm Management Devices Market CM (ECG, ILR, Event Monitors, MCT), CRM (Defibrillator (ICD (CRT D), External Defibrillators (AED)), Pacemaker (CRT P, Dual Chamber Pacemaker)), End User (Hospitals) - Global Forecast to 2024
出版日期: 2019年10月29日內容資訊: 英文 187 Pages
簡介

心臟監測 (CM) 、心律管理 (CRM) 設備市場預測將從2019年的207億美元,擴大到2024年250億美元。市場在2019年∼2024年間,預測將以年複合成長率 (CAGR) 3.9%的速度成長。

本報告提供全球心臟監測 (CM) 、心律管理 (CRM) 設備市場相關調查分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 心臟監測 (CM) 、心律管理 (CRM) 設備:市場概要
  • 亞太地區 - 心臟監測 (CM) 、心律管理 (CRM) 設備市場佔有率:各終端用戶,各國
  • 心律管理 (CRM) 設備市場:各類型
  • 心臟監測 (CM) 、心律管理 (CRM) 設備市場各地區概述

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 課題

第6章 心臟監測 (CM) 設備市場:各類型

  • 簡介
  • 心電圖 (ECG)
    • 靜態心電圖
    • 動態心電圖
    • Holter心電圖監測儀
  • 植入式迴路記錄器 (ILR)
  • 行動心電遙測 (MCT) 設備
  • 心摶出量監視 (COM) 設備
  • 心臟事件記錄器
  • 智慧穿戴式心電圖 (ECG) 監測

第7章 心律管理 (CRM) 設備市場:各類型

  • 簡介
  • 心臟去顫器
  • 心律調節器

第8章 心臟監測 (CM) 、心律管理 (CRM) 設備市場:各終端用戶

  • 簡介
  • 醫院,診所,心臟中心
  • ASC
  • 其他

第9章 心臟監測 (CM) 、心律管理 (CRM) 設備市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第10章 競爭情形

  • 概要
  • 市場佔有率分析
  • 競爭模式
  • 競爭領導製圖

第11章 企業簡介

  • ABBOTT LABORATORIES
  • MEDTRONIC, PLC
  • BOSTON SCIENTIFIC CORPORATION
  • GE HEALTHCARE
  • KONINKLIJKE PHILIPS N.V.
  • BIOTRONIK
  • 旭化成
  • MICROPORT SCIENTIFIC CORPORATION
  • HILL-ROM HOLDINGS
  • 日本光電工業
  • SCHILLER
  • BIOTELEMETRY
  • ACS DIAGNOSTICS
  • BPL MEDICAL TECHNOLOGIES
  • BTL
  • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
  • LEPU MEDICAL TECHNOLOGY
  • SHREE PACETRONIX
  • OSYPKA AG
  • ALIVECOR, INC.

第12章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MD 1038

"Increasing prevalence of CVD to drive the growth of this market."

The cardiac monitoring and cardiac rhythm management devices market is projected to reach USD 25.0 billion by 2024 from USD 20.7 billion in 2019, at a CAGR of 3.9%. Growth in this market is primarily driven by the increasing incidence of cardiovascular diseases; technological advancements; increasing investments, funds, and grants for research on CM & CRM devices; and the growing preference for wearable cardiac devices. However, the dearth of skilled professionals and frequent product recalls are expected to challenge market growth in the coming years

"ILRs are expected to grow at the highest CAGR during the forecast period."

Based on type, the CM devices market is segmented into ECG devices, ILR, MCT, event monitors, COM devices, and smart ECG monitors. Of these, ILRs are expected to grow at the highest CAGR during the forecast period. The advantages of ILRs are a higher rate of diagnosis of heart rhythm problems than external recorders, long-term monitoring of up to three years, large storage capacity, remote monitoring, and detection & reduction of recurrent syncopes. Owing to their benefits, the demand for these devices is expected to increase across the globe

"The defibrillators segment is expected to grow at the highest CAGR during the forecast period."

Based on type, the CRM devices market is segmented into defibrillators and pacemakers. The defibrillators segment is expected to grow at the highest CAGR in the forecast period. Technological advancements in defibrillators, rising prevalence of CVDs, and the growing focus on providing public-access defibrillators are some of the major factors expected to propel the growth of this market.

"The ambulatory surgical centers segment is expected to grow at the highest CAGR during the forecast period."

The ambulatory surgical centers segment is expected to grow at the highest CAGR in the forecast period. Growing number of ASCs and physicians are realizing the benefits of performing cardiovascular procedures at ASCs, thus attributing to its high CAGR during the forecast period.

"APAC to grow at the highest CAGR during the forecast period."

In the CM & CRM devices market, the APAC market, particularly in China, Japan, India, and the Association of Southeast Asian Nations (ASEAN) countries, is expected to witness the highest growth in the next five years. This is due to the rising prevalence of CVDs in APAC countries, attributed to the increasing adoption of sedentary lifestyles, changing diets, increasing stress, and habitual smoking and drinking.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the CM & CRM devices market.

  • By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%
  • By Designation: C-level Executives: 27%, Directors: 18%, and Others: 55%
  • By Region: North America: 50%, Europe: 20%, APAC: 15%, and RoW: 15%

The CM & CRM devices market comprises major players such as Medtronic (Ireland), Boston Scientific (US), Abbott Laboratories (US), GE Healthcare (US), BIOTRONIK (Germany), Hill-Rom Holdings (US), and Koninklijke Philips (Netherlands). The study includes an in-depth competitive analysis of these key players in the CM & CRM devices market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:

The market study covers the CM & CRM devices market across various segments. It aims at estimating the market size and the growth potential of this market across different segments, based on CM devices by type, and based on CRM devices by type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall CM & CRM devices market and its subsegments. This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, opportunities, and challenges.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKETS COVERED
  • 1.4 YEARS CONSIDERED FOR THE STUDY
  • 1.5 CURRENCY
  • 1.6 LIMITATIONS
  • 1.7 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 SECONDARY DATA
    • 2.2.1 KEY DATA FROM SECONDARY SOURCES
  • 2.3 PRIMARY DATA
    • 2.3.1 KEY DATA FROM PRIMARY SOURCES
  • 2.4 MARKET SIZE ESTIMATION
    • 2.4.1 REVENUE MAPPING-BASED MARKET ESTIMATION
  • 2.5 DATA TRIANGULATION
    • 2.5.1 ASSUMPTIONS FOR THE STUDY
    • 2.5.2 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES: MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SHARE, BY END USER & COUNTRY (2018)
  • 4.3 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE (2017-2024)
  • 4.4 GEOGRAPHIC SNAPSHOT OF THE CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS: DRIVERS, RESTRAINTS, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing incidence of cardiovascular disease
      • 5.2.1.2 Technological advancements
      • 5.2.1.3 Increasing investments, funds, and grants for research on CM & CRM devices
      • 5.2.1.4 Growing preference for wearable cardiac devices
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Increasing incidence of CIED infections
    • 5.2.3 CHALLENGES
      • 5.2.3.1 Dearth of skilled professionals with expertise in electrocardiography and cardiac rhythm management devices
      • 5.2.3.2 Frequent product recalls

6 CARDIAC MONITORING DEVICES MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 ECG DEVICES
    • 6.2.1 RESTING ECG DEVICES
      • 6.2.1.1 Low cost, ease of use, and simplicity have driven the adoption of resting ECG devices
    • 6.2.2 STRESS ECG DEVICES
      • 6.2.2.1 Flexibility in use has driven the demand for stress ECG devices, but high cost has negatively affected the market
    • 6.2.3 HOLTER MONITORS
      • 6.2.3.1 Short duration of monitoring is a key restraint to market growth
  • 6.3 IMPLANTABLE LOOP RECORDERS
    • 6.3.1 HIGH COST AND LIMITED APPLICATIONS HAVE HINDERED DEMAND GROWTH
  • 6.4 MOBILE CARDIAC TELEMETRY DEVICES
    • 6.4.1 INCREASING DEMAND FOR CARDIAC MONITORING SOLUTIONS IN HOME CARE SETTINGS IS PROPELLING MARKET GROWTH
  • 6.5 CARDIAC OUTPUT MONITORING DEVICES
    • 6.5.1 INCREASING NUMBER OF CARDIAC SURGERIES WILL DRIVE THE DEMAND FOR COM DEVICES
  • 6.6 EVENT MONITORS
    • 6.6.1 EVENT MONITORS MARKET, BY TYPE
      • 6.6.1.1 Pre-symptom event monitors
        • 6.6.1.1.1 Large storage capacity of pre-symptom event monitors makes them ideal for long-term monitoring
      • 6.6.1.2 Post-symptom event monitors
        • 6.6.1.2.1 Emergence of handheld, wireless, and remote monitors will drive market growth
    • 6.6.2 EVENT MONITORS MARKET, BY TECHNOLOGY
      • 6.6.2.1 Autodetect monitors
        • 6.6.2.1.1 Autodetect monitors are ideal for patients who are unable to reliably trigger monitors
      • 6.6.2.2 Manual event monitors
        • 6.6.2.2.1 Manual monitors can be pre-symptom or post-symptom, but rely on the patient to be triggered
  • 6.7 SMART ECG MONITORS
    • 6.7.1 LACK OF DATA SECURITY HINDERS THE GROWTH OF THE SMART MONITORS MARKET TO SOME EXTENT

7 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE

  • 7.1 INTRODUCTION
  • 7.2 DEFIBRILLATORS
    • 7.2.1 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
      • 7.2.1.1 Transvenous implantable cardioverter defibrillators (T-ICDs)
        • 7.2.1.1.1 Biventricular implantable cardioverter defibrillators/cardiac resynchronization therapy defibrillators
        • 7.2.1.1.1.1 Biventricular ICDs/CRT-Ds are preferred for heart failure patients
        • 7.2.1.1.2 Dual-chamber implantable cardioverter defibrillators
        • 7.2.1.1.2.1 Benefits of dual-chamber ICDs, such as higher diagnostic accuracy, make them ideal for patients with tachycardia episodes
        • 7.2.1.1.3 Single-chamber implantable cardioverter defibrillators
        • 7.2.1.1.3.1 Launch of MRI-compatible single-chamber ICDs will drive market growth
      • 7.2.1.2 Subcutaneous implantable cardioverter defibrillators
        • 7.2.1.2.1 Safety and efficacy of S-ICDs in the prevention of sudden cardiac arrest will boost their adoption
    • 7.2.2 EXTERNAL DEFIBRILLATORS
      • 7.2.2.1 Automated external defibrillators
        • 7.2.2.1.1 Semi-automated external defibrillators
        • 7.2.2.1.1.1 Semi-automated external defibrillators accounted for the largest share of the AEDs market in 2018
        • 7.2.2.1.2 Fully automated external defibrillators
        • 7.2.2.1.2.1 Benefits of fully automatic AEDs and higher accuracy will drive market growth
      • 7.2.2.2 Manual external defibrillators
        • 7.2.2.2.1 North America dominates the manual defibrillators market
      • 7.2.2.3 Wearable cardioverter defibrillators
        • 7.2.2.3.1 Ease of use and the noninvasive nature of wearable cardioverter defibrillators will support market growth
  • 7.3 PACEMAKERS
    • 7.3.1 PACEMAKERS MARKET, BY IMPLANTABILITY
      • 7.3.1.1 Implantable pacemakers
        • 7.3.1.1.1 Introduction of leadless and MRI-safe devices has boosted device popularity
      • 7.3.1.2 External pacemakers
        • 7.3.1.2.1 Increasing number of open-heart surgeries will drive the demand for external pacemakers
    • 7.3.2 PACEMAKERS MARKET, BY TYPE
      • 7.3.2.1 Dual-chamber pacemakers
        • 7.3.2.1.1 Dual-chamber pacemakers are the most commonly implanted pacemakers for bradycardia-a key factor driving market growth
      • 7.3.2.2 Single-chamber pacemakers
        • 7.3.2.2.1 Introduction of leadless pacemakers will stimulate demand in this product segment
      • 7.3.2.3 Biventricular/CRT pacemakers
        • 7.3.2.3.1 High cost and unfavorable reimbursement scenario have hindered market growth

8 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS, CLINICS, & CARDIAC CENTERS
    • 8.2.1 GROWING NUMBER OF CARDIAC IMPLANT PROCEDURES TO DRIVE MARKET GROWTH
  • 8.3 AMBULATORY SURGERY CENTERS
    • 8.3.1 GROWING NUMBER OF ASCS IN THE US TO DRIVE THE ADOPTION OF CM & CRM DEVICES
  • 8.4 OTHER END USERS

9 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 US
      • 9.2.1.1 Growing number of FDA approvals for CM & CRM devices to support market growth in the US
    • 9.2.2 CANADA
      • 9.2.2.1 Growing focus of government and private organizations on providing funding for research to drive market growth
  • 9.3 EUROPE
    • 9.3.1 GERMANY
      • 9.3.1.1 Increasing healthcare expenditure to drive market growth
    • 9.3.2 FRANCE
      • 9.3.2.1 Rising prevalence of heart failure to drive the adoption of CRT devices in France
    • 9.3.3 UK
      • 9.3.3.1 Rising demand for home-based cardiac monitoring devices to support market growth
    • 9.3.4 ITALY
      • 9.3.4.1 Increasing incidence of atrial fibrillation among the elderly will drive market growth in Italy
    • 9.3.5 SPAIN
      • 9.3.5.1 Rising awareness and growing device adoption indicate strong growth in the coming years
    • 9.3.6 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 JAPAN
      • 9.4.1.1 High healthcare expenditure and favorable reimbursement and insurance coverage to support market growth in Japan
    • 9.4.2 CHINA
      • 9.4.2.1 Rising prevalence of CVDs and government support for infrastructural improvements will drive market growth
    • 9.4.3 INDIA
      • 9.4.3.1 Government initiatives will propel market growth in India
    • 9.4.4 REST OF ASIA PACIFIC
  • 9.5 REST OF THE WORLD

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 MARKET SHARE ANALYSIS, 2018
  • 10.3 COMPETITIVE SCENARIO
    • 10.3.1 CONTRACTS, PARTNERSHIPS, & AGREEMENTS (2016-2019)
    • 10.3.2 PRODUCT LAUNCHES & APPROVALS (2016-2019)
    • 10.3.3 EXPANSIONS (2016-2019)
    • 10.3.4 ACQUISITIONS (2016-2019)
  • 10.4 COMPETITIVE LEADERSHIP MAPPING (2019)
    • 10.4.1 VENDOR INCLUSION CRITERIA
    • 10.4.2 VISIONARY LEADERS
    • 10.4.3 DYNAMIC DIFFERENTIATORS
    • 10.4.4 EMERGING COMPANIES

11 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View)*

  • 11.1 ABBOTT LABORATORIES
  • 11.2 MEDTRONIC, PLC
  • 11.3 BOSTON SCIENTIFIC CORPORATION
  • 11.4 GE HEALTHCARE
  • 11.5 KONINKLIJKE PHILIPS N.V.
  • 11.6 BIOTRONIK
  • 11.7 ASAHI KASEI CORPORATION
  • 11.8 MICROPORT SCIENTIFIC CORPORATION
  • 11.9 HILL-ROM HOLDINGS
  • 11.10 NIHON KOHDEN CORPORATION
  • 11.11 SCHILLER
  • 11.12 BIOTELEMETRY
  • 11.13 ACS DIAGNOSTICS
  • 11.14 BPL MEDICAL TECHNOLOGIES
  • 11.15 BTL
  • 11.16 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
  • 11.17 LEPU MEDICAL TECHNOLOGY
  • 11.18 SHREE PACETRONIX
  • 11.19 OSYPKA AG
  • 11.20 ALIVECOR, INC.

Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: RECENT PRODUCT INNOVATIONS IN THE CM & CRM MARKET
  • TABLE 2: KEY PRODUCT RECALLS
  • TABLE 3: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 4: ECG DEVICES & EVENT MONITORS MARKET, 2017-2024 (UNITS)
  • TABLE 5: ECG DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 6: ECG DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 7: NORTH AMERICA: ECG DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 8: EUROPE: ECG DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 9: APAC: ECG DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 10: RESTING ECG DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11: STRESS ECG DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 12: HOLTER MONITORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 13: IMPLANTABLE LOOP RECORDERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 14: NORTH AMERICA: IMPLANTABLE LOOP RECORDERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 15: EUROPE: IMPLANTABLE LOOP RECORDERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 16: APAC: IMPLANTABLE LOOP RECORDERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 17: MOBILE CARDIAC TELEMETRY DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 18: TYPES OF COM DEVICES
  • TABLE 19: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 20: NORTH AMERICA: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 21: EUROPE: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 22: APAC: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 23: EVENT MONITORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 24: NORTH AMERICA: EVENT MONITORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 25: EUROPE: EVENT MONITORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 26: APAC: EVENT MONITORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 27: EVENT MONITORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 28: PRE-SYMPTOM EVENT MONITORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 29: POST-SYMPTOM EVENT MONITORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 30: INDICATIVE LIST OF SMART ECG MONITORS
  • TABLE 31: SMART ECG MONITORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 32: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 33: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (UNITS)
  • TABLE 34: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 35: DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 36: NORTH AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 2017-2024(USD MILLION)
  • TABLE 37: EUROPE: DEFIBRILLATORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 38: APAC: DEFIBRILLATORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 39: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 40: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 41: NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2017-2024(USD MILLION)
  • TABLE 42: EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 43: APAC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 44: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 45: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 46: BIVENTRICULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 47: DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 48: SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 49: SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 50: EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 51: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 52: INDICATIVE LIST OF AEDS THAT HAVE RECEIVED PREMARKET APPROVAL FROM THE FDA (2018-2019)
  • TABLE 53: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 54: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 55: MANUAL EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 56: WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 57: PACEMAKERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 58: NORTH AMERICA: PACEMAKERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 59: EUROPE: PACEMAKERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 60: APAC: PACEMAKERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 61: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024(USD MILLION)
  • TABLE 62: IMPLANTABLE PACEMAKERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 63: NORTH AMERICA: IMPLANTABLE PACEMAKERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 64: EUROPE: IMPLANTABLE PACEMAKERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 65: APAC: IMPLANTABLE PACEMAKERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 66: EXTERNAL PACEMAKERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 67: NORTH AMERICA: EXTERNAL PACEMAKERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 68: EUROPE: EXTERNAL PACEMAKERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 69: APAC: EXTERNAL PACEMAKERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 70: PACEMAKERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 71: DUAL-CHAMBER PACEMAKERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 72: SINGLE-CHAMBER PACEMAKERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 73: BIVENTRICULAR/CRT PACEMAKERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 74: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 75: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR HOSPITALS, CLINICS, & CARDIAC CENTERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 76: NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR HOSPITALS, CLINICS, & CARDIAC CENTERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 77: EUROPE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR HOSPITALS, CLINICS, & CARDIAC CENTERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 78: APAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR HOSPITALS, CLINICS, & CARDIAC CENTERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 79: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 80: NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 81: EUROPE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 82: APAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 83: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR OTHER END USERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 84: NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 85: EUROPE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 86: APAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 87: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 88: CARDIAC MONITORING DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 89: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 90: NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 91: NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 92: NORTH AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 93: NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 94: NORTH AMERICA: ECG DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 95: NORTH AMERICA: EVENT MONITORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 96: NORTH AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 97: NORTH AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 98: NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 99: NORTH AMERICA: T-ICDS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 100: NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 101: NORTH AMERICA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 102: NORTH AMERICA: PACEMAKERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 103: NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 104: US: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 105: US: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 106: US: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 107: US: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 108: US: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 109: CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 110: CANADA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 111: CANADA: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 112: CANADA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 113: CANADA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 114: EUROPE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 115: EUROPE: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 116: EUROPE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 117: EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 118: EUROPE: ECG DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 119: EUROPE: EVENT MONITORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 120: EUROPE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 121: EUROPE: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 122: EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 123: EUROPE: T-ICDS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 124: EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 125: EUROPE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 126: EUROPE: PACEMAKERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 127: EUROPE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 128: GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 129: GERMANY: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 130: GERMANY: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 131: GERMANY: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 132: GERMANY: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 133: FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 134: FRANCE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 135: FRANCE: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 136: FRANCE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 137: FRANCE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 138: UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 139: UK: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 140: UK: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 141: UK: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 142: UK: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 143: ITALY: NUMBER OF ELDERLY CITIZENS WITH ATRIAL FIBRILLATION (IN THOUSANDS)
  • TABLE 144: ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 145: ITALY: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 146: ITALY: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 147: ITALY: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 148: ITALY: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 149: SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 150: SPAIN: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 151: SPAIN: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 152: SPAIN: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 153: SPAIN: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 154: ROE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 155: ROE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 156: ROE: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 157: ROE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 158: ROE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 159: APAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 160: APAC: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 161: APAC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 162: APAC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 163: APAC: ECG DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 164: APAC: EVENT MONITORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 165: APAC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 166: APAC: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 167: APAC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 168: APAC: T-ICDS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 169: APAC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 170: APAC: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 171: APAC: PACEMAKERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 172: APAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 173: JAPAN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 174: JAPAN: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 175: JAPAN: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 176: JAPAN: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 177: JAPAN: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 178: CHINA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 179: CHINA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 180: CHINA: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 181: CHINA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 182: CHINA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 183: INDIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 184: INDIA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 185: INDIA: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 186: INDIA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 187: INDIA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 188: ROAPAC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 189: ROAPAC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 190: ROAPAC DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 191: ROAPAC: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 192: ROAPAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 193: ROW: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 194: ROW: ECG DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 195: ROW: EVENT MONITORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 196: ROW: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 197: ROW: DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 198: ROW: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 199: ROW: T-ICDS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 200: ROW: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 201: ROW: PACEMAKERS MARKET, BY IMPLANTABILITY, 2017-2024 (USD MILLION)
  • TABLE 202: ROW: PACEMAKERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 203: ROW: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2017-2024 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 4: MARKET SIZE ESTIMATION: CRM DEVICES MARKET
  • FIGURE 5: MARKET DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 7: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 8: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2019 VS. 2024
  • FIGURE 9: GEOGRAPHICAL SNAPSHOT OF THE CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET
  • FIGURE 10: INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES WILL DRIVE MARKET GROWTH
  • FIGURE 11: HOSPITALS, CLINICS, & CARDIAC CENTERS DOMINATED THE CM & CRM DEVICES MARKET IN THE APAC IN 2018
  • FIGURE 12: DEFIBRILLATORS TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 13: CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 14: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 15: NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SNAPSHOT
  • FIGURE 16: FRANCE: CRM DEVICE IMPLANTATION, 2015-2018
  • FIGURE 17: APAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SNAPSHOT
  • FIGURE 18: JAPAN: HEALTH EXPENDITURE AS A SHARE OF GDP, 2005-2016
  • FIGURE 19: CRM DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2018
  • FIGURE 20: MNM VENDOR DIVE COMPARISON MATRIX: CM & CRM DEVICES MARKET
  • FIGURE 21: ABBOTT LABORATORIES: COMPANY SNAPSHOT (2018)
  • FIGURE 22: MEDTRONIC: COMPANY SNAPSHOT (2018)
  • FIGURE 23: BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2018)
  • FIGURE 24: GE HEALTHCARE: COMPANY SNAPSHOT (2018)
  • FIGURE 25: PHILIPS: COMPANY SNAPSHOT (2018)
  • FIGURE 26: ASAHI KASEI: COMPANY SNAPSHOT (2018)
  • FIGURE 27: MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2018)
  • FIGURE 28: HILL-ROM HOLDINGS: COMPANY SNAPSHOT (2018)
  • FIGURE 29: NIHON KOHDEN: COMPANY SNAPSHOT (2018)
  • FIGURE 30: BIOTELEMETRY: COMPANY SNAPSHOT (2018)
  • FIGURE 31: LEPU MEDICAL: COMPANY SNAPSHOT (2016)
  • FIGURE 32: SHREE PACETRONIX: COMPANY SNAPSHOT (2018)
Back to Top